The US commercial drug development company Ore Pharmaceuticals has named Mark Gabrielson president and chief executive officer. He succeeds Charles Dimmler. Mr Gabrielson serves on the company's board of directors and was most recently managing general partner of the financial services firm p-Value Capital.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?